Navigation Links
Blocking Protein May Stem COPD
Date:3/18/2010

Study in mice could lead to new treatments for smoking-related diseases,,,,

THURSDAY, March 18 (HealthDay News) -- Blocking a specific protein reduced or prevented smoking-related lung inflammation in mice, Australian researchers report.

Inflammation is associated with chronic pulmonary obstructive disease (COPD) and many other health problems caused by smoking.

In the study, researchers from the University of Melbourne focused on a protein called granulocyte macrophage-colony stimulating factor (GM-CSF), which controls the growth, activation and survival of leukocytes, the white blood cells that are part of the immune system and that play a role in the development of COPD.

The researchers exposed mice to the equivalent of smoke from nine cigarettes a day for four days. Half the mice were treated with a GM-CSF blocking agent (anti-GM-CSF). After four days, the rodents' lung tissue was examined for the presence of inflammatory cells.

"We found that anti-GM-CSF strongly reduced the number of potentially harmful white blood cells that infiltrate the lung after smoke exposure, as well as inhibiting the pro-inflammatory cytokine tumor necrosis factor (TNF)-a, the chemokine macrophage inflammatory protein-2 (MIP-2), which coordinates the movement of white blood cells into the lung," the study's lead researcher, Ross Vlahos, a senior research fellow with the lung disease research group at the University of Melbourne, said in a news release from the American Thoracic Society. "It also inhibited the protease MMP-12, which is known as one of the main enzymes able to destroy lung tissue."

"Cigarette smoke-exposed mice that were treated with an anti-GM-CSF had significantly less lung inflammation in comparison to untreated mice," Vlahos said. "This indicates that GM-CSF is a key mediator in smoke-induced lung inflammation, and its neutralization may have therapeutic implications in diseases such as COPD."

The findings could lead to new ways to fight COPD and other smoking-related diseases, the researchers indicated.

The study was published online recently in the American Journal of Respiratory and Critical Care Medicine.

More information

The American Lung Association has more about smoking.



-- Robert Preidt



SOURCE: American Thoracic Society, news release, March 18, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Blocking Potent Oxidant Could Prevent Morphine Tolerance
2. Blocking protein kills prostate cancer cells, inhibits tumor growth, Jefferson scientists find
3. Blocking the effect of inflammation-causing cells lowered prostate cancer cells invasion
4. Blocking signaling protein prevents prostate cancer spread, Jefferson scientists find
5. Pennsylvania Medical Society and AARP Criticize Senator Specter for Blocking Bill to Protect Access to Doctors and Improve Medicare
6. Blocking molecular pathway with whimsical name possible therapeutic target for pancreatic cancer
7. Blocking Oncogene Can Stop Spread of Ovarian Cancer
8. Stopping ovarian cancer by blocking proteins coded by notorious gene
9. Blocking toxic effects could make clot-buster safer
10. Blocking protein leads to fewer, smaller skin cancer tumors
11. Protein May Hold Key to Blocking Allergy-Induced Asthma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/17/2017)... KOREA (PRWEB) , ... July ... ... receipt of CE marking for its faster PICOPLUS 450 ps pulse width ... picosecond- and nanosecond-domain 1,064-nm neodymium-doped yttrium-aluminum-garnet lasers in tissue-mimicking phantom’ featured in ...
(Date:7/17/2017)... ... July 17, 2017 , ... Summer camp season ... to ensure children are protected from Lyme and other tick-borne diseases. , With ... an increased risk not only for the tick-borne illness, but for its various ...
(Date:7/17/2017)... ... July 17, 2017 , ... HMP , a ... with the Texas Academy of Family Physicians (TAFP) for the 6th ... at the Hyatt Regency Dallas in Dallas, Texas.     , CRS and TAFP will ...
(Date:7/17/2017)... ... 17, 2017 , ... Jordan Search Consultants (JSC), a national ... for Springfield Clinic’s Chief Executive Officer (CEO) in Springfield, IL. Working with JSC ... with more than 30 years of experience, as the new CEO. , ...
(Date:7/17/2017)... Aliso Viejo, CA (PRWEB) , ... July 17, 2017 , ... ... Pro X. These minimalistic layouts can be used to complement vlogs, professional productions, and ... using the click of a mouse. Manipulate camera controls to make beautiful and unique ...
Breaking Medicine News(10 mins):
(Date:6/30/2017)... June 30, 2017  AVACEN Medical (AVACEN) announced the publication of ... describes the use of its AVACEN Treatment Method to ... fibromyalgia. ... AVACEN Medical ... chronic widespread pain. It affects approximately 200 to 400 million people worldwide ...
(Date:6/27/2017)...  Therapix Biosciences Ltd. (Nasdaq: TRPX ) ... development of cannabinoid-based drugs, today announced that the Company ... New York, NY on Wednesday, ... offering (IPO) of American Depository Shares (ADSs) listed on ... Dr. Elran Haber, Ph.D., Chief Executive Officer of Therapix, ...
(Date:6/20/2017)... Netherlands and LAGUNA HILLS, Calif. ... the presentation of new data that validate the use ... risk stratify patients with multiple myeloma (MM). In a ... the European Hematology Association (EHA) in Madrid, ... value of MMprofiler for identifying high-risk elderly patients. ...
Breaking Medicine Technology: